Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

A comparison of machine learning techniques for classification of HIV patients with antiretroviral therapy-induced mitochondrial toxicity from those without mitochondrial toxicity.

Lee JS, Paintsil E, Gopalakrishnan V, Ghebremichael M.

BMC Med Res Methodol. 2019 Nov 27;19(1):216. doi: 10.1186/s12874-019-0848-z.

2.

Purification and characterization of β-galactosidase from newly isolated Aspergillus terreus (KUBCF1306) and evaluating its efficacy on breast cancer cell line (MCF-7).

Vidya B, Palaniswamy M, Angayarkanni J, Ayub Nawaz K, Thandeeswaran M, Krishna Chaithanya K, Tekluu B, Muthusamy K, Gopalakrishnan VK.

Bioorg Chem. 2019 Nov 15:103442. doi: 10.1016/j.bioorg.2019.103442. [Epub ahead of print]

PMID:
31761411
3.

Nature-Based Solutions Can Compete with Technology for Mitigating Air Emissions Across the United States.

Gopalakrishnan V, Ziv G, Hirabayashi S, Bakshi BR.

Environ Sci Technol. 2019 Nov 19;53(22):13228-13237. doi: 10.1021/acs.est.9b01445. Epub 2019 Nov 6.

PMID:
31691557
4.

G-quadruplex Structures Contribute to Differential Radiosensitivity of the Human Genome.

Kumari N, Vartak SV, Dahal S, Kumari S, Desai SS, Gopalakrishnan V, Choudhary B, Raghavan SC.

iScience. 2019 Nov 22;21:288-307. doi: 10.1016/j.isci.2019.10.033. Epub 2019 Oct 21.

5.

Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines.

Koroth J, Nirgude S, Tiwari S, Gopalakrishnan V, Mahadeva R, Kumar S, Karki SS, Choudhary B.

BMC Complement Altern Med. 2019 Oct 21;19(1):273. doi: 10.1186/s12906-019-2685-3.

6.

EpiSAFARI: Sensitive detection of valleys in epigenetic signals for enhancing annotations of functional elements.

Harmanci A, Serin Harmanci A, Swaminathan J, Gopalakrishnan V.

Bioinformatics. 2019 Sep 10. pii: btz702. doi: 10.1093/bioinformatics/btz702. [Epub ahead of print]

PMID:
31501853
7.

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.

Jacquelot N, Yamazaki T, Roberti MP, Duong CPM, Andrews MC, Verlingue L, Ferrere G, Becharef S, Vétizou M, Daillère R, Messaoudene M, Enot DP, Stoll G, Ugel S, Marigo I, Foong Ngiow S, Marabelle A, Prevost-Blondel A, Gaudreau PO, Gopalakrishnan V, Eggermont AM, Opolon P, Klein C, Madonna G, Ascierto PA, Sucker A, Schadendorf D, Smyth MJ, Soria JC, Kroemer G, Bronte V, Wargo J, Zitvogel L.

Cell Res. 2019 Oct;29(10):846-861. doi: 10.1038/s41422-019-0224-x. Epub 2019 Sep 3.

PMID:
31481761
8.

Gut Microbiome Signatures are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.

Galloway-Peña JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, Wargo JA, Do KA, Jenq RR, Kontoyiannis DP, Shelburne SA.

Clin Infect Dis. 2019 Aug 22. pii: ciz777. doi: 10.1093/cid/ciz777. [Epub ahead of print]

PMID:
31436833
9.

Towards precision critical care management of blood pressure in hemorrhagic stroke patients using dynamic linear models.

Liu Y, Manners J, Bittar Y, Chou SH, Gopalakrishnan V.

PLoS One. 2019 Aug 5;14(8):e0220283. doi: 10.1371/journal.pone.0220283. eCollection 2019.

10.

Screening and GC-MS profiling of ethanolic extract of Tylophora pauciflora.

Starlin T, Prabha PS, Thayakumar BKA, Gopalakrishnan VK.

Bioinformation. 2019 Jun 15;15(6):425-429. doi: 10.6026/97320630015425. eCollection 2019.

11.

Induction and Resuscitation of the Viable but Non-culturable (VBNC) State in Acidovorax citrulli, the Causal Agent of Bacterial Fruit Blotch of Cucurbitaceous Crops.

Kan Y, Jiang N, Xu X, Lyu Q, Gopalakrishnan V, Walcott R, Burdman S, Li J, Luo L.

Front Microbiol. 2019 May 15;10:1081. doi: 10.3389/fmicb.2019.01081. eCollection 2019.

12.

Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.

Treichel AM, Hamieh L, Nathan NR, Tyburczy ME, Wang JA, Oyerinde O, Raiciulescu S, Julien-Williams P, Jones AM, Gopalakrishnan V, Moss J, Kwiatkowski DJ, Darling TN.

Genet Med. 2019 Nov;21(11):2594-2604. doi: 10.1038/s41436-019-0520-3. Epub 2019 May 22.

PMID:
31114024
13.

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.

Reddy SM, Reuben A, Barua S, Jiang H, Zhang S, Wang L, Gopalakrishnan V, Hudgens CW, Tetzlaff MT, Reuben JM, Tsujikawa T, Coussens LM, Wani K, He Y, Villareal L, Wood A, Rao A, Woodward WA, Ueno NT, Krishnamurthy S, Wargo JA, Mittendorf EA.

Cancer Immunol Res. 2019 Jun;7(6):1025-1035. doi: 10.1158/2326-6066.CIR-18-0619. Epub 2019 May 1.

PMID:
31043414
14.

Janeway Lesions: a Painless Manifestation of Infective Endocarditis.

Panginikkod S, Gopalakrishnan V, Parikh M, Gupta N.

J Gen Intern Med. 2019 Jul;34(7):1360-1361. doi: 10.1007/s11606-018-4770-6. Epub 2019 Apr 18. No abstract available.

PMID:
31001722
15.

p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.

Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB.

Sci Rep. 2019 Apr 16;9(1):6161. doi: 10.1038/s41598-019-42450-0.

16.

Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.

Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V.

J Neurooncol. 2019 May;142(3):409. doi: 10.1007/s11060-019-03162-7.

PMID:
30968268
17.

A survey on literature based discovery approaches in biomedical domain.

Gopalakrishnan V, Jha K, Jin W, Zhang A.

J Biomed Inform. 2019 May;93:103141. doi: 10.1016/j.jbi.2019.103141. Epub 2019 Mar 9. Review.

PMID:
30857950
18.

The microbiome, cancer, and cancer therapy.

Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA.

Nat Med. 2019 Mar;25(3):377-388. doi: 10.1038/s41591-019-0377-7. Epub 2019 Mar 6. Review.

PMID:
30842679
19.

Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.

Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V.

J Neurooncol. 2019 May;142(3):395-407. doi: 10.1007/s11060-019-03091-5. Epub 2019 Feb 20. Erratum in: J Neurooncol. 2019 Apr 9;:.

PMID:
30788681
20.

Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma.

Dobson THW, Tao RH, Swaminathan J, Maegawa S, Shaik S, Bravo-Alegria J, Sharma A, Kennis B, Yang Y, Callegari K, Haltom AR, Taylor P, Kogiso M, Qi L, Khatua S, Goldman S, Lulla RR, Fangusaro J, MacDonald TJ, Li XN, Hawkins C, Rajaram V, Gopalakrishnan V.

Sci Signal. 2019 Jan 22;12(565). pii: eaan8680. doi: 10.1126/scisignal.aan8680.

PMID:
30670636
21.

Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.

Gopalakrishnan V, Yao J, Steagall WK, Avila NA, Taveira-DaSilva AM, Stylianou M, Chen MY, Moss J.

Chest. 2019 May;155(5):962-971. doi: 10.1016/j.chest.2019.01.004. Epub 2019 Jan 17.

PMID:
30660784
22.

Qualitative assessment of published studies on pulpotomy medicaments for primary molar teeth.

Gopalakrishnan V, Anthonappa R, Ekambaram M, King NM.

J Investig Clin Dent. 2019 May;10(2):e12389. doi: 10.1111/jicd.12389. Epub 2019 Jan 11. Review.

PMID:
30635970
23.

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

Sade-Feldman M, Yizhak K, Bjorgaard SL, Ray JP, de Boer CG, Jenkins RW, Lieb DJ, Chen JH, Frederick DT, Barzily-Rokni M, Freeman SS, Reuben A, Hoover PJ, Villani AC, Ivanova E, Portell A, Lizotte PH, Aref AR, Eliane JP, Hammond MR, Vitzthum H, Blackmon SM, Li B, Gopalakrishnan V, Reddy SM, Cooper ZA, Paweletz CP, Barbie DA, Stemmer-Rachamimov A, Flaherty KT, Wargo JA, Boland GM, Sullivan RJ, Getz G, Hacohen N.

Cell. 2019 Jan 10;176(1-2):404. doi: 10.1016/j.cell.2018.12.034. No abstract available.

24.

Implicating or exonerating the gut microbiome in blood-borne infection.

Gopalakrishnan V, Jenq RR.

Nat Med. 2018 Dec;24(12):1788-1789. doi: 10.1038/s41591-018-0270-9. No abstract available.

PMID:
30510253
25.

Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.

Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR.

Nat Med. 2019 Jan;25(1):188. doi: 10.1038/s41591-018-0305-2.

PMID:
30479380
26.

Erratum: Radiation therapy-induced aortoesophageal fistula: a case report and review of literature.

Parikh MP, Sherid M, Panginikkod S, Rawal HA, Gopalakrishnan V.

Gastroenterol Rep (Oxf). 2018 Nov;6(4):320. doi: 10.1093/gastro/goy035. Epub 2018 Sep 11.

27.

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.

Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR.

Nat Med. 2018 Dec;24(12):1804-1808. doi: 10.1038/s41591-018-0238-9. Epub 2018 Nov 12. Erratum in: Nat Med. 2018 Nov 27;:.

28.

The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.

Cogdill AP, Gaudreau PO, Arora R, Gopalakrishnan V, Wargo JA.

Trends Immunol. 2018 Nov;39(11):900-920. doi: 10.1016/j.it.2018.09.007. Review.

PMID:
30392721
29.

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

Sade-Feldman M, Yizhak K, Bjorgaard SL, Ray JP, de Boer CG, Jenkins RW, Lieb DJ, Chen JH, Frederick DT, Barzily-Rokni M, Freeman SS, Reuben A, Hoover PJ, Villani AC, Ivanova E, Portell A, Lizotte PH, Aref AR, Eliane JP, Hammond MR, Vitzthum H, Blackmon SM, Li B, Gopalakrishnan V, Reddy SM, Cooper ZA, Paweletz CP, Barbie DA, Stemmer-Rachamimov A, Flaherty KT, Wargo JA, Boland GM, Sullivan RJ, Getz G, Hacohen N.

Cell. 2018 Nov 1;175(4):998-1013.e20. doi: 10.1016/j.cell.2018.10.038. Erratum in: Cell. 2019 Jan 10;176(1-2):404.

30.

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA.

Nat Med. 2018 Dec;24(12):1942. doi: 10.1038/s41591-018-0252-y.

PMID:
30361511
31.

Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA.

Nat Med. 2018 Dec;24(12):1941. doi: 10.1038/s41591-018-0251-z.

PMID:
30361510
32.

Characterization of DNA double-strand break repair pathways in diffuse large B cell lymphoma.

Gopalakrishnan V, Dahal S, Radha G, Sharma S, Raghavan SC, Choudhary B.

Mol Carcinog. 2019 Feb;58(2):219-233. doi: 10.1002/mc.22921. Epub 2018 Oct 25.

PMID:
30298948
33.

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA.

Nat Med. 2018 Nov;24(11):1649-1654. doi: 10.1038/s41591-018-0197-1. Epub 2018 Oct 8. Erratum in: Nat Med. 2018 Oct 25;:. Nat Med. 2018 Oct 25;:.

34.

Chest CT Scan at Radiation Dose of a Posteroanterior and Lateral Chest Radiograph Series: A Proof of Principle in Lymphangioleiomyomatosis.

Hu-Wang E, Schuzer JL, Rollison S, Leifer ES, Steveson C, Gopalakrishnan V, Yao J, Machado T, Jones AM, Julien-Williams P, Moss J, Chen MY.

Chest. 2019 Mar;155(3):528-533. doi: 10.1016/j.chest.2018.09.007. Epub 2018 Oct 3.

35.

Preclinical Models of Pediatric Brain Tumors-Forging Ahead.

Dobson THW, Gopalakrishnan V.

Bioengineering (Basel). 2018 Oct 2;5(4). pii: E81. doi: 10.3390/bioengineering5040081. Review.

36.

Tunable structure priors for Bayesian rule learning for knowledge integrated biomarker discovery.

Balasubramanian JB, Gopalakrishnan V.

World J Clin Oncol. 2018 Sep 14;9(5):98-109. doi: 10.5306/wjco.v9.i5.98.

37.

Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joining in a Ligase IV dependent manner.

Vartak SV, Swarup HA, Gopalakrishnan V, Gopinatha VK, Ropars V, Nambiar M, John F, Kothanahally SKS, Kumari R, Kumari N, Ray U, Radha G, Dinesh D, Pandey M, Ananda H, Karki SS, Srivastava M, Charbonnier JB, Choudhary B, Mantelingu K, Raghavan SC.

FEBS J. 2018 Nov;285(21):3959-3976. doi: 10.1111/febs.14661. Epub 2018 Oct 8.

38.

Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration.

Callegari K, Maegawa S, Bravo-Alegria J, Gopalakrishnan V.

Cell Commun Signal. 2018 Sep 18;16(1):60. doi: 10.1186/s12964-018-0275-5.

39.

The use of intra-articular analgesics to improve outcomes after temporomandibular joint arthrocentesis: a review.

Gopalakrishnan V, Nagori SA, Roy Chowdhury SK, Saxena V.

Oral Maxillofac Surg. 2018 Dec;22(4):357-364. doi: 10.1007/s10006-018-0720-z. Epub 2018 Sep 8. Review.

PMID:
30196484
40.

The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: A systematic review and meta-analysis.

Nagori SA, Jose A, Gopalakrishnan V, Roy ID, Chattopadhyay PK, Roychoudhury A.

J Oral Rehabil. 2018 Dec;45(12):998-1006. doi: 10.1111/joor.12698. Epub 2018 Aug 3.

PMID:
30024045
41.

'J' waves and hypothermia.

Panginikkod S, Gupta NM, Gopalakrishnan V, Songolo T, Parikh MP, Friedman HJ.

QJM. 2018 Dec 1;111(12):903-904. doi: 10.1093/qjmed/hcy138. No abstract available.

PMID:
29939369
42.

MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.

Dhar SS, Zhao D, Lin T, Gu B, Pal K, Wu SJ, Alam H, Lv J, Yun K, Gopalakrishnan V, Flores ER, Northcott PA, Rajaram V, Li W, Shilatifard A, Sillitoe RV, Chen K, Lee MG.

Mol Cell. 2018 Jun 7;70(5):825-841.e6. doi: 10.1016/j.molcel.2018.04.028. Epub 2018 May 31.

43.

A computational framework for the detection of subcortical brain dysmaturation in neonatal MRI using 3D Convolutional Neural Networks.

Ceschin R, Zahner A, Reynolds W, Gaesser J, Zuccoli G, Lo CW, Gopalakrishnan V, Panigrahy A.

Neuroimage. 2018 Sep;178:183-197. doi: 10.1016/j.neuroimage.2018.05.049. Epub 2018 May 21.

44.

Optimization of a secondary VOI protocol for lung imaging in a clinical CT scanner.

Larsen TC, Gopalakrishnan V, Yao J, Nguyen CP, Chen MY, Moss J, Wen H.

J Appl Clin Med Phys. 2018 Jul;19(4):271-280. doi: 10.1002/acm2.12354. Epub 2018 May 21.

45.

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.

Andrews MC, Reuben A, Gopalakrishnan V, Wargo JA.

Front Immunol. 2018 May 4;9:946. doi: 10.3389/fimmu.2018.00946. eCollection 2018. Review.

46.

Infection is the chief cause of mortality and non-death censored graft loss in the first year after renal transplantation in a resource limited population: A single centre study.

Gopalakrishnan V, Agarwal SK, Aggarwal S, Mahajan S, Bhowmik D, Bagchi S.

Nephrology (Carlton). 2019 Apr;24(4):456-463. doi: 10.1111/nep.13401.

PMID:
29761588
47.

The gut microbiota influences anticancer immunosurveillance and general health.

Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G.

Nat Rev Clin Oncol. 2018 Jun;15(6):382-396. doi: 10.1038/s41571-018-0006-2. Review.

PMID:
29636538
48.

The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.

Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA.

Cancer Cell. 2018 Apr 9;33(4):570-580. doi: 10.1016/j.ccell.2018.03.015. Review.

49.

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort.

Gopalakrishnan V, Jones AM, Julien-Williams P, Machado T, Danner RL, Swigris JJ, Paine R 3rd, Lozier JN, Moss J.

ERJ Open Res. 2018 Mar 20;4(1). pii: 00121-2017. doi: 10.1183/23120541.00121-2017. eCollection 2018 Jan.

50.

Linking Associations of Rare Low-Abundance Species to Their Environments by Association Networks.

Karpinets TV, Gopalakrishnan V, Wargo J, Futreal AP, Schadt CW, Zhang J.

Front Microbiol. 2018 Mar 7;9:297. doi: 10.3389/fmicb.2018.00297. eCollection 2018.

Supplemental Content

Loading ...
Support Center